Gilead Sciences (GILD)

Asegua Therapeutics LLC • Forty Seven, Inc. • Forty Seven Holdings, LLC • Gilead Alberta, LLC • Gilead Apollo, LLC • Gilead Biopharmaceutics US LLC • Gilead Calistoga, LLC • Gilead Connecticut, Inc. • Gilead Holdings, LLC • Gilead Pharmasset LLC ...

IRS number

943047598

GILD stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$100.44

Low target

$80.00

High target

$125.00

Latest filings (excl ownership)

View all

8-K/A

Departure of Directors or Certain Officers

12 Dec 24

8-K

Entry into a Material Definitive Agreement

20 Nov 24

424B5

Prospectus supplement for primary offering

15 Nov 24

FWP

Free writing prospectus

13 Nov 24

424B5

Prospectus supplement for primary offering

12 Nov 24

Gilead Sciences Announces Third Quarter 2024 Financial Results

6 Nov 24

8-K

Departure of Directors or Certain Officers

17 Jul 24

8-K

Amendments to Articles of Incorporation or Bylaws

9 May 24

8-K

Gilead Sciences Announces First Quarter 2024 Financial Results

25 Apr 24

Transcripts

View all

GILD

Earnings call transcript

2024 Q3

6 Nov 24

GILD

Earnings call transcript

2024 Q2

8 Aug 24

GILD

Earnings call transcript

2024 Q1

25 Apr 24

GILD

Earnings call transcript

2023 Q4

6 Feb 24

GILD

Earnings call transcript

2023 Q3

7 Nov 23

GILD

Earnings call transcript

2023 Q2

3 Aug 23

GILD

Earnings call transcript

2023 Q2

3 Aug 23

GILD

Earnings call transcript

2023 Q1

27 Apr 23

GILD

Earnings call transcript

2022 Q4

2 Feb 23

GILD

Earnings call transcript

2022 Q3

28 Oct 22

Latest ownership filings

View all

Xilio Therapeutics, Inc.

Notice of proposed sale of securities

Financial summary

Financial statements Chart GILD financial data

Quarter (USD)	Sep 24	Dec 23	Sep 23	Jun 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	5.04 bn	5.04 bn	5.04 bn	5.04 bn	5.04 bn	5.04 bn
Cash burn (monthly)	349.33 mm	(no burn)	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	974.81 mm	n/a	n/a	n/a	n/a	n/a
Cash remaining	4.06 bn	n/a	n/a	n/a	n/a	n/a
Runway (months of cash)	11.6	n/a	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

GILD institutional ownership history Ownership history

82.2% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	1675	1652	+1.4%
Opened positions	169	137	+23.4%
Closed positions	146	171	-14.6%
Increased positions	607	634	-4.3%
Reduced positions	675	669	+0.9%

13F shares	Current	Prev Q	Change
Total value	82.11 tn	67.63 tn	+21.4%
Total shares	1.02 bn	1.04 bn	-1.2%
Total puts	9.73 mm	8.95 mm	+8.8%
Total calls	10.32 mm	11.84 mm	-12.9%
Total put/call ratio	0.9	0.8	+24.8%

Largest owners	Shares	Value	Change
BLK BlackRock	121.94 mm	$10.22 tn	NEW
Vanguard	115.34 mm	$9.67 tn	+0.1%
Capital World Investors	76.55 mm	$6.42 tn	+0.4%
Capital Research Global Investors	61.80 mm	$5.18 tn	+2.3%
STT State Street	60.17 mm	$5.04 tn	+1.4%
Wellington Management	34.60 mm	$2.90 tn	+50.9%
FMR	33.16 mm	$2.78 tn	+79.4%
Dodge & Cox	33.05 mm	$2.77 tn	-0.2%
Geode Capital Management	27.54 mm	$2.30 tn	+2.1%
MS Morgan Stanley	17.25 mm	$1.45 tn	-10.8%

Largest transactions	Shares	Bought/sold	Change
BLK BlackRock	121.94 mm	+121.94 mm	NEW
BLK BlackRock	0.00	-120.63 mm	EXIT
Norges Bank	0.00	-17.39 mm	EXIT
FMR	33.16 mm	+14.68 mm	+79.4%
Wellington Management	34.60 mm	+11.67 mm	+50.9%
Pacer Advisors	781.59 k	-7.11 mm	-90.1%
Citadel Advisors	5.02 mm	+4.74 mm	+1702.5%
Two Sigma Advisers	2.49 mm	-3.77 mm	-60.2%
Two Sigma Investments	698.67 k	-2.63 mm	-79.0%
D. E. Shaw & Co.	741.20 k	-2.60 mm	-77.8%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

GILD insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
18 Dec 24	Gilead Sciences	Common Stock	Buy	Acquire P	No	No	1.04	1,759,978	1.83 mm	9,105,451
18 Dec 24	Gilead Sciences	Prefunded Warrants Common Stock	Buy	Acquire P	No	No	1.0399	6,092,816	6.34 mm	9,975,266
16 Dec 24	Dickinson Andrew D	Common Stock	Sell	Dispose S	No	Yes	91.96	8,500	781.66 k	132,373
10 Dec 24	Dickinson Andrew D	Common Stock	Payment of exercise	Dispose F	No	No	92.34	1,686	155.69 k	140,873
10 Dec 24	Dickinson Andrew D	Common Stock	Option exercise	Acquire M	No	No	0	3,640	0.00	142,559
10 Dec 24	Dickinson Andrew D	RSU Common Stock	Option exercise	Dispose M	No	No	0	3,640	0.00	35,487
10 Dec 24	Mercier Johanna	Common Stock	Payment of exercise	Dispose F	No	No	92.34	1,739	160.58 k	75,140
10 Dec 24	Mercier Johanna	Common Stock	Option exercise	Acquire M	No	No	0	3,752	0.00	76,879
10 Dec 24	Mercier Johanna	RSU Common Stock	Option exercise	Dispose M	No	No	0	3,752	0.00	36,193
10 Dec 24	Daniel Patrick O'Day	Common Stock	Payment of exercise	Dispose F	No	No	92.34	4,762	439.72 k	501,528